Shares of microcap biotech firm Alexza Pharmaceuticals (ALXA -14.6%) get slammed after the FDA...

|About: Alexza Pharmaceuticals, Inc. (ALXA)|By:, SA News Editor

Shares of microcap biotech firm Alexza Pharmaceuticals (ALXA -14.6%) get slammed after the FDA says it needs an additional three months to complete its review of the company's new drug application for Adasuve, a schizophrenic and bipolar disorder treatment.